Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: Potential value in the clinic

Lung Cancer

Volumn 81, Issue 2, 2013, Pages 213-217

  Li, Ling ^a   Ren, Shuhua ^b   Zhang, Yingjian ^a   Guan, Yihui ^b   Zhao, Jun ^b   Liu, Jun ^c   Wang, Qun ^d   Chen, Gang ^e   Chen, Haiquan ^a   Xiang, Jiaqing ^a   Fu, Xiaolong ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

^e TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

FDG; Non small cell lung cancer; Occult nodal metastasis; PET CT; Standard uptake value (SUV); Stereotactic ablative radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER RISK; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; OCCULT NODAL METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

FDG; NON-SMALL CELL LUNG CANCER; OCCULT NODAL METASTASIS; PET/CT; STANDARD UPTAKE VALUE (SUV); STEREOTACTIC ABLATIVE RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879881523     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.04.012     Document Type: Article

References (20)

1. Birim O., Kappetein A.P., Stijnen T., et al. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg 2005, 79:375-382.
2. Toloza E.M., Harpole L., McCrory D.C. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003, 123(1 Suppl.):137S-146S.
3. 1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT - a prospective study. Radiology 2006, 241:501-509.
4. 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer 2007, 109:1068-1077.
5. Yendamuri S., Sharma R., Demmy M., et al. Temporal trends in outcomes following sublobar and lobar resections for small (≤2cm) non-small cell lung cancers - a Surveillance Epidemiology End Results database analysis. J Surg Res 2012, [Epub ahead of print].
6. Ricardi U., Filippi A.R., Guarneri A., et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 2010, 68:72-77.
7. Grills I.S., Mangona V.S., Welsh R., et al. Outcomes after stereotactic lung radiotherapy or segmentectomy for stage I non-small cell lung cancer. J Clin Oncol 2010, 28:928-935.
8. Lagerwaard F.J., Verstegen N.E., Haasbeek C.J., et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012, 83:348-353.
9. Onishi H., Shirato H., Nagata Y., et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small cell lung cancer: can SBRT be comparable to surgery?. Int J Radiat Oncol Biol Phys 2011, 81:1352-1358.
10. Burdick M.J., Stephans K.L., Reddy C.A., et al. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010, 15(78):1033-1039.
11. Wang J., Welch K., Wang L., et al. Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis. Clin Lung Cancer 2012, 13:81-89.
12. 0 non-small cell lung cancer patients after negative uptake of positron emission tomography/computed tomography scan. Eur J Cardiothorac Surg 2010, 37:1168-1174.
13. Park H.K., Jeon K., Koh W.J., et al. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology 2010, 15:1179-1184.
14. Veeramachaneni N.K., Battafarano R.J., Meyers B.F., et al. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg 2008, 33:466-469.
15. Casiraghi M., Travaini L.L., Maisonneuve P., et al. Lymph node involvement in T1 non-small cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?. Eur J Cardiothorac Surg 2011, 39:e38-e43.
16. Li X., Zhang H., Xing L., et al. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study. Radiother Oncol 2012, 102:246-250.
17. Cerfolio R.J., Ojha B., Bryant A.S., et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall ell lung cancer. Ann Thorac Surg 2004, 78:1017-1023.
18. max) of lung cancer and lymph node metastasis on FDG-PET. Ann Nucl Med 2009, 23:269-275.
19. Lee Y., Auh S.L., Wang Y., et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009, 114:589-595.
20. max) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 2008, 3:6-12.